Needs Of Women With Substance Use Disorders In Lebanon

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
H02AB09	SOLU CORTEF ACT-O-VIAL	B	Hydrocortisone (sodium succinate) - 250mg	250mg	Injectable lyophilised powder for solution+diluent	421,967 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L
G03GA01	CHORIOMON	BioHuman	Human Chorionic Gonadotrophin - 5,000IU	5,000IU	Injectable lyophilised powder for solution+diluent	4,031,528 L.L
G03GA04	FOSTIMON	BioHuman	Urofollitropin - 150IU	150IU	Injectable lyophilised powder for solution+diluent	36,347,120 L.L
G03GA04	FOSTIMON	BioHuman	Urofollitropin - 75IU	75IU	Injectable lyophilised powder for solution+diluent	15,744,000 L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
M01AC02	SORAL	G	Tenoxicam - 20mg/2ml	20mg/2ml	Injectable lyophilised powder for solution+solvent	588,603 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml		Injectable oily suspension	423,310 L.L
J01CR02	VAAMOX IV	G	Amoxicillin - 1g, Clavulanic Acid - 200mg		Injectable powder	225,766 L.L
J01CR02	VAAMOX IV	G	Amoxicillin - 1g, Clavulanic Acid - 200mg		Injectable powder	2,150,148 L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 500mg		Injectable powder	L.L
J01DB04	CEFAZOL IM/IV	G	Cefazolin (sodium) - 1g	1g	Injectable powder	5,375,370 L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 500mg		Injectable powder	41,289,202 L.L
J01DD04	CEFAXONE	G	Ceftriaxone - 1g	1g	Injectable powder	403,153 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
L01FX02	MYLOTARG	BioTech	Gemtuzumab Ozogamicin - 4.5mg	4.5mg	Injectable powder	748,160,090 L.L
H02AB09	HYDROCORTISONE ORBUCELL	G	Hydrocortisone (sodium succinate) - 100mg	100mg	Injectable powder	1,091,712 L.L
J01DH03	ERTANZ	G	Ertapenem - 1g	1g	Injectable powder	2,521,049 L.L
J01DH51	SYNERGIC	G	Imipenem - 500mg, Cilastatin - 500mg		Injectable powder	1,142,266 L.L
N01AH06	REMIFENTANIL MEDIS	G	Remifentanil (HCl) - 1mg	1mg	Injectable powder	1,101,951 L.L
N01AH06	REMIFENTANIL MEDIS	G	Remifentanil (HCl) - 5mg	5mg	Injectable powder	2,576,146 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 0.5g/2ml, Lidocaine (ampoule) -	0.5g/2ml	Injectable powder + solvent	342,285 L.L
L04AC02	SIMULECT	BioTech	Basiliximab - 20mg	20mg	Injectable powder + solvent	131,822,828 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 1g/3.5ml, Lidocaine (ampoule) -	1g/3.5ml	Injectable powder + solvent	599,719 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 75IU	75IU	Injectable powder + solvent	24,771,315 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 150IU	150IU	Injectable powder + solvent	41,777,992 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 900IU	900IU	Injectable powder + solvent	25,830,983 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	L.L

احتياجات النساء اللواتي يعانين اضطرابات استخدام المواد المسببة للإدمان في لبنان - ٢٠١٩